Literature DB >> 16699018

Effect of apolipoprotein E on the cerebral load of latent herpes simplex virus type 1 DNA.

Javier S Burgos1, Carlos Ramirez, Isabel Sastre, Fernando Valdivieso.   

Abstract

Herpes simplex virus type 1 (HSV-1) is neurotropic and enters a latent state lasting the lifetime of the host. This pathogen has recently been proposed as a risk factor for Alzheimer's disease (AD) in conjunction with apolipoprotein E4 (ApoE4). In a murine acute infection model, we showed that viral neuroinvasiveness depends directly on the overall ApoE dosage and especially on the presence of isoform ApoE4. If an interaction between ApoE and HSV-1 is involved in AD, it may occur during latency rather than during acute infection. Certainly, ApoE plays an important role in late-onset AD, i.e., at a time in life when the majority of people harbor HSV-1 in their nervous system. In the present work, wild-type, APOE knockout, APOE3, and APOE4 transgenic mice were used to analyze the influence of the ApoE profile on the levels of latent virus DNA. The knockout mice had significantly lower concentrations of the virus in the nervous system than the wild-type mice, while the APOE4 mice had very high levels in the brain compared to the APOE3 animals. ApoE4 seems to facilitate HSV-1 latency in the brain much more so than ApoE3. The APOE dosage correlated directly with the HSV-1 DNA concentration in the brain, strengthening the hypothesis that HSV-1, together with ApoE, might be involved in AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16699018      PMCID: PMC1472141          DOI: 10.1128/JVI.00006-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

1.  Herpes simplex virus type 1 and Alzheimer's disease.

Authors:  Ruth F Itzhaki; Curtis B Dobson; Matthew A Wozniak
Journal:  Ann Neurol       Date:  2004-02       Impact factor: 10.422

2.  Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease.

Authors:  Isamu Mori; Yoshinobu Kimura; Hironobu Naiki; Rokuro Matsubara; Tohru Takeuchi; Takashi Yokochi; Yukihiro Nishiyama
Journal:  J Med Virol       Date:  2004-08       Impact factor: 2.327

3.  Isolation of latent herpes simplex virus from the superior cervical and vagus ganglions of human beings.

Authors:  K G Warren; S M Brown; Z Wroblewska; D Gilden; H Koprowski; J Subak-Sharpe
Journal:  N Engl J Med       Date:  1978-05-11       Impact factor: 91.245

4.  "Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?".

Authors:  M J Ball
Journal:  Can J Neurol Sci       Date:  1982-08       Impact factor: 2.104

5.  Detection of herpes-simplex viral genome in brain tissue.

Authors:  L W Sequiera; L C Jennings; L H Carrasco; M A Lord; A Curry; R N Sutton
Journal:  Lancet       Date:  1979-09-22       Impact factor: 79.321

6.  Acute and recurrent infection with herpes simplex virus in the mouse: a model for studying latency and recurrent disease.

Authors:  T J Hill; H J Field; W A Blyth
Journal:  J Gen Virol       Date:  1975-09       Impact factor: 3.891

Review 7.  Herpes simplex virus type 1, apolipoprotein E and Alzheimer' disease.

Authors:  Ruth Itzhaki
Journal:  Herpes       Date:  2004-06

Review 8.  Genetic vulnerability following traumatic brain injury: the role of apolipoprotein E.

Authors:  N Nathoo; R Chetty; J R van Dellen; G H Barnett
Journal:  Mol Pathol       Date:  2003-06

Review 9.  Apolipoprotein E and Alzheimer disease.

Authors:  W J Strittmatter; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

10.  Herpes simplex type 1 DNA in human brain tissue.

Authors:  N W Fraser; W C Lawrence; Z Wroblewska; D H Gilden; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

View more
  46 in total

1.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

2.  Antiviral agents in Alzheimer's disease: hope for the future?

Authors:  Matthew A Wozniak; Ruth F Itzhaki
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

3.  Using HSV-1 genome phylogenetics to track past human migrations.

Authors:  Aaron W Kolb; Cécile Ané; Curtis R Brandt
Journal:  PLoS One       Date:  2013-10-16       Impact factor: 3.240

4.  Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: phylogeny, sequence variability, and SNP distribution.

Authors:  Aaron W Kolb; Marie Adams; Eric L Cabot; Mark Craven; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-25       Impact factor: 4.799

Review 5.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

6.  Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1.

Authors:  Partha S Bhattacharjee; Donna M Neumann; Timothy P Foster; Saadallah Bouhanik; Christian Clement; Dass Vinay; Hilary W Thompson; James M Hill
Journal:  Exp Eye Res       Date:  2008-05-18       Impact factor: 3.467

7.  Changes in immunoglobulin levels related to herpes simplex virus type 1 brain infection in pregnant mice.

Authors:  Javier S Burgos; Carlos Ramirez; Anna Brachet; Juan M Alfaro; Isabel Sastre; Fernando Valdivieso
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

Review 8.  Viral Hypothesis and Antiviral Treatment in Alzheimer's Disease.

Authors:  D P Devanand
Journal:  Curr Neurol Neurosci Rep       Date:  2018-07-14       Impact factor: 5.081

9.  Herpes simplex virus type 1 and Alzheimer's disease: the autophagy connection.

Authors:  Ruth F Itzhaki; S Louise Cosby; Matthew A Wozniak
Journal:  J Neurovirol       Date:  2008-01       Impact factor: 2.643

Review 10.  Apolipoprotein E genotype and hepatitis C, HIV and herpes simplex disease risk: a literature review.

Authors:  Inga Kuhlmann; Anne Marie Minihane; Patricia Huebbe; Almut Nebel; Gerald Rimbach
Journal:  Lipids Health Dis       Date:  2010-01-28       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.